Fresh frozen plasma transfusion does not affect outcomes following hepatic resection for hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 16, Issue 44, 2010, Pages 5603-5610

  Tomimaru, Yoshito ^a   Wada, Hiroshi ^a   Marubashi, Shigeru ^a   Kobayashi, Shogo ^a   Eguchi, Hidetoshi ^a   Takeda, Yutaka ^a   Tanemura, Masahiro ^a   Noda, Takehiro ^a   Umeshita, Koji ^a   Doki, Yuichiro ^a   Mori, Masaki ^a   Nagano, Hiroaki ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Fresh frozen plasma; Hepatocellular carcinoma; Surgery; Transfusion

Indexed keywords

FRESH FROZEN PLASMA;

ADULT; AGED; ARTICLE; ASCITES; BILE LEAKAGE; BLEEDING; CANCER MORTALITY; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; ILEUS; INCIDENCE; INTRAOPERATIVE PERIOD; KIDNEY DYSFUNCTION; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER FUNCTION TEST; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERIOPERATIVE COMPLICATION; PLASMA TRANSFUSION; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; WOUND INFECTION;

EID: 78649714382     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i44.5603     Document Type: Article

References (36)

1. Farges O, Malassagne B, Flejou JF, Balzan S, Sauvanet A, Belghiti J. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg 1999; 229: 210-215
2. Hsia CY, Lui WY, Chau GY, King KL, Loong CC, Wu CW. Perioperative safety and prognosis in hepatocellular carcinoma patients with impaired liver function. J Am Coll Surg 2000; 190: 574-579
3. Nagao T, Inoue S, Goto S, Mizuta T, Omori Y, Kawano N, Morioka Y. Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann Surg 1987; 205: 33-40
4. Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, Corvera C, Weber S, Blumgart LH. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 2002; 236: 397-406; discussion 406-407
5. Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K, Takayama T, Makuuchi M. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 2003; 138: 1198-1206; discussion 1206
6. Wallace EL. Monitoring the nation's blood supply. Transfusion 2003; 43: 299-301
7. Stanworth SJ, Brunskill SJ, Hyde CJ, McClelland DB, Murphy MF. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol 2004; 126: 139-152
8. Stanworth SJ, Hyde CJ, Murphy MF. Evidence for indications of fresh frozen plasma. Transfus Clin Biol 2007; 14: 551-556
9. Franco D, Smadja C, Kahwaji F, Grange D, Kemeny F, Traynor O. Segmentectomies in the management of liver tumors. Arch Surg 1988; 123: 519-522
10. Makuuchi M, Takayama T, Gunvén P, Kosuge T, Yamazaki S, Hasegawa H. Restrictive versus liberal blood transfusion policy for hepatectomies in cirrhotic patients. World J Surg 1989; 13: 644-648
11. Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, Kawasaki S. Surgery for small liver cancers. Semin Surg Oncol 1993; 9: 298-304
12. Melendez JA, Arslan V, Fischer ME, Wuest D, Jarnagin WR, Fong Y, Blumgart LH. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg 1998; 187: 620-625
13. Isbister JP. Adverse reactions to plasma and plasma components. Anaesth Intensive Care 1993; 21: 31-38
14. MacLennan S, Barbara JA. Risks and side effects of therapy with plasma and plasma fractions. Best Pract Res Clin Haematol 2006; 19: 169-189
15. Bux J, Sachs UJ. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 2007; 136: 788-799
16. Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H, Yamaguchi N, Mizuno S, Makuuchi M. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery 1994; 115: 303-309
17. Hanazaki K, Kajikawa S, Shimozawa N, Matsushita A, Machida T, Shimada K, Yazawa K, Koide N, Adachi W, Amano J. Perioperative blood transfusion and survival following curative hepatic resection for hepatocellular carcinoma. Hepatogastroenterology 2005; 52: 524-529
18. Japanese Ministry of Health, Labour and Welfare. Blood transfusion guideline. 3rd ed. Tokyo: Jiho Co., 2005
19. Poon RT. Recent advances in techniques of liver resection. Surg Technol Int 2004; 13: 71-77
20. Makuuchi M, Imamura H, Sugawara Y, Takayama T. Progress in surgical treatment of hepatocellular carcinoma. Oncology 2002; 62 Suppl 1: 74-81
21. Liver Cancer Study Group of Japan. General rules for the clinical and pathological study of primary liver cancer (in Japanese), 5th ed. Tokyo: Kanehara, 2008
22. Torzilli G, Makuuchi M, Inoue K, Takayama T, Sakamoto Y, Sugawara Y, Kubota K, Zucchi A. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 1999; 134: 984-992
23. Wei AC, Tung-Ping Poon R, Fan ST, Wong J. Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg 2003; 90: 33-41
24. Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, Wong J. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg 2004; 240: 698-708; discussion 708-710
25. Martin RC 2nd, Jarnagin WR, Fong Y, Biernacki P, Blumgart LH, DeMatteo RP. The use of fresh frozen plasma after major hepatic resection for colorectal metastasis: is there a standard for transfusion? J Am Coll Surg 2003; 196: 402-409
26. Hellstern P, Haubelt H. Indications for plasma in massive transfusion. Thromb Res 2002; 107 Suppl 1: S19-S22
27. O'Shaughnessy DF, Atterbury C, Bolton Maggs P, Murphy M, Thomas D, Yates S, Williamson LM. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004; 126: 11-28
28. Holland LL, Foster TM, Marlar RA, Brooks JP. Fresh frozen plasma is ineffective for correcting minimally elevated international normalized ratios. Transfusion 2005; 45: 1234-1235
29. Foster RS Jr, Costanza MC, Foster JC, Wanner MC, Foster CB. Adverse relationship between blood transfusions and survival after colectomy for colon cancer. Cancer 1985; 55: 1195-1201
30. Crowe JP, Gordon NH, Fry DE, Shuck JM, Hubay CA. Breast cancer survival and perioperative blood transfusion. Surgery 1989; 106: 836-841
31. Little AG, Wu HS, Ferguson MK, Ho CH, Bowers VD, Segalin A, Staszek VM. Perioperative blood transfusion adversely affects prognosis of patients with stage I non-small-cell lung cancer. Am J Surg 1990; 160: 630-632; discussion 633
32. Tartter PI. The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg 1992; 216: 633-638
33. Motoyama S, Saito R, Kamata S, Kitamura M, Okuyama M, Imano H, Nakamura M, Suzuki H, Omokawa S, Motohashi Y, Ogawa J. Survival advantage of using autologous blood transfusion during surgery for esophageal cancer. Surg Today 2002; 32: 951-958
34. Voogt PJ, van de Velde CJ, Brand A, Hermans J, Stijnen T, Bloem R, Leer JW, Zwaveling A, van Rood JJ. Perioperative blood transfusion and cancer prognosis. Different effects of blood transfusion on prognosis of colon and breast cancer patients. Cancer 1987; 59: 836-843
35. Donohue JH, Williams S, Cha S, Windschitl HE, Witzig TE, Nelson H, Fitzgibbons RJ Jr, Wieand HS, Moertel CG. Perioperative blood transfusions do not affect disease recurrence of patients undergoing curative resection of colorectal carcinoma: a Mayo/North Central Cancer Treatment Group study. J Clin Oncol 1995; 13: 1671-1678
36. Kaibori M, Saito T, Matsui K, Yamaoka M, Kamiyama Y. Impact of fresh frozen plasma on hepatectomy for hepatocellular carcinoma. Anticancer Res 2008; 28: 1749-1755